why choose us

First received: November 10, 2023

Clinical Trial: Evaluating Pediatric Ivermectin in Children Under 15 kg (EPIC-15)

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Scabies

Study Type: INTERVENTIONAL


Official Title: A Randomized Trial to Assess the Safety, Pharmacokinetics, Acceptability, and Efficacy of Pediatric Oral Ivermectin in Scabies Infected Children Weighing 5 to Less Than 15 Kilograms

Brief Summary: The EPIC-15 trial will evaluate the safety, pharmacokinetics, acceptability, and efficacy of pediatric ivermectin (CHILD-IVITAB) in scabies infected children weighing 5 to less than 15 kg.This trial will support future efforts to expand the indication of ivermectin treatment to infants weighing 5 to less than 15 kg to treat numerous NTDs, allowing this young age group equitable access to the numerous benefits of pediatric ivermectin therapy

Read more